MVP

MEDICALDEV FPO [MVP]
Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analgesia during short procedures. The company also distributes asthma and chronic obstructive pulmonary disease products, such space chambers, peak flow meters, portable nebulisers, and silicon face mask. Medical Developments International Limited was founded in 1972 and is headquartered in Scoresby, Australia.
Healthcare · ASX Small Cap
$0.3750 -3.8%

Updated 23 Jul 2026 · Signals refresh every scan

Get alerts when MVP triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track MVP — Free

Active Signals

Bullish Signals

  • RSI drifting toward oversold territory — worth watching
  • MACD momentum is losing steam
  • Stochastic is deep in oversold territory — bounce conditions forming
  • Above-average volume (1.7x) on a red day — sellers in control
  • Drifting lower — down 8.5% over the last 5 days
  • Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
  • Cash positive / operating cashflow positive
  • 4C filed 2026-04-23
  • Low P/S ratio (1.1x)
  • Moderate revenue growth (+8%)
  • Near 52-week low (5% of range)
  • Small-cap ($20-100M)
  • New substantial holder(s) (1)
  • CANSLIM A: Turned profitable
  • CANSLIM I: Institutional ownership (26%)
  • Sentiment is mixed — no strong consensus either way
  • RBA hiking (-3pts)

Risk Signals

  • Broke below 20-day support — that's a level the market was defending, and it just gave way
  • Below the 200-day average — the long-term trend is still working against it
  • Negative profit margins (-1%)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • Long-term momentum is negative — down 43% over the past year
Ask Scout AI about MVP
"What's driving MVP today?" "How does MVP compare to peers?" "Key risks for MVP?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Change in substantial holding
NONE Change in substantial holding
HIGH Becoming a substantial holder

Recent ASX Announcements

2026-07-01 Change in substantial holding
2026-06-03 Becoming a substantial holder
2026-06-02 Change in substantial holding

Key Metrics

$43.4M
Market Cap
133K
Avg Volume
1.7x
Vol Ratio
$0.36 — $0.77
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-0.8%
ROE
-1.1%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsimprovingCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 67%
LLeader vs LaggardlaggardRS: -12
IInstitutional SponsorshippassInst: 26%
MMarket DirectionneutralNeutral

Sector: Healthcare

102 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
PIQ +23.3%SLD -18.1%ADR -17.9%IDT -17.1%VBS -14.3%
Compare:MVP vs PIQMVP vs SLDMVP vs ADR
Scout Pro — Deeper Analysis for MVP
Try Pro free for 30 days
Share this analysis

Track MVP and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required